{"id":"W4367850074","doi":"10.1183/13993003.e6104-2023","title":"<i>ERJ</i> Podcast April 2023: Global Initiative for Chronic Obstructive Lung Disease 2023 Report","year":2023,"lang":"en","type":"letter","venue":"European Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health; Agenzia Italiana del Farmaco, Ministero della Salute; Canadian Institutes of Health Research; Sunovion; AstraZeneca; CSL Behring; Chiesi Farmaceutici; Sanofi; American Thoracic Society; Pfizer; COPD Foundation; GlaxoSmithKline; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Obstructive lung disease; Pulmonary disease; Lung disease; Medicine; Internal medicine; Cardiology; Intensive care medicine; Lung","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002156392,0.0006744209,0.0007303677,0.0006398167,0.003513389,0.003223947,0.0009884927,0.02228627,0.03768038],"category_scores_gemma":[0.01083569,0.0004422256,0.0009154214,0.0006646605,0.001067335,0.002310903,0.001125005,0.02313368,0.03565342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002953954,"about_ca_system_score_gemma":0.003446745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01160811,"about_ca_topic_score_gemma":0.02524037,"domain_scores_codex":[0.9988137,0.0002389006,0.0001476905,0.0001377883,0.0004391688,0.0002228133],"domain_scores_gemma":[0.9952947,0.001503234,0.0003432006,0.0001568867,0.001509169,0.001192613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001071056,0.000006302424,0.00008568996,0.00001164781,8.660847e-7,0.00008944861,0.00000722888,0.000002727135,0.00002064368,0.000172692,0.9983124,0.001279613],"study_design_scores_gemma":[0.00005605647,0.00003055522,0.001935951,0.0002555809,0.000008031328,0.0003768158,0.0001679034,0.00008859492,0.0000878985,0.0009256271,0.9960426,0.0000244619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.0002434559,0.001737231,0.0000846299,0.8765259,0.09528048,0.00005675316,0.0006827554,0.00009903139,0.02528969],"genre_scores_gemma":[0.002850346,0.002170765,0.0002277591,0.8163818,0.08048637,0.000126036,0.0005159292,0.0001205575,0.09712045],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03768038,"threshold_uncertainty_score":0.1260535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04917508630734325,"score_gpt":0.3272480399324333,"score_spread":0.27807295362509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}